Stanford Medicine researchers on the hunt for an elusive cardiac fibrosis drug were surprised when a malaria drug with ancient origins emerged as their top candidate.
Bryant Lin has taken his diagnosis of stage IV ‘never-smoker’ lung cancer, which disproportionately affects those of Asian descent, and turned it into a medical school course. He hopes the world takes notes along with the students and Stanford Medicine community.
Custom designing proteins — a breakthrough recognized by the latest Nobel Prize in chemistry — could yield treatments that stop the worst of COVID-19 before it begins.
Technological advancements allow diabetes patients to monitor their glucose levels remotely. Stanford Medicine researchers are refining similar tools for Parkinson’s patients and the providers they don’t see often enough.
Stanford Medicine scientists are studying why even brief trips into space can weaken muscle and heart tissue, mimicking decades of aging on Earth.
What does it mean that H5N1 bird flu, also known as highly pathogenic avian influenza A, is spreading among dairy cows? And how should U.S. health systems — and consumers of milk products — be responding?
Often misunderstood and undertreated, bipolar disorder has received close attention from Stanford Medicine clinicians and researchers for more than 30 years.
A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Stanford Medicine neurologist Mike Greicius explains why these drugs, so promising in theory, don’t appear to be helping patients much if at all.
Stanford Medicine's Jeffrey Goldberg believes a young, underexplored class of therapies called gliotherapeutics, which target and harness glia, will ultimately provide important new directions for treatment.
The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
Stanford Medicine researchers are designing vaccines that might protect people from not merely individual viral strains but broad ranges of them. The ultimate goal: a vaccine with coverage so broad it can protect against viruses never before encountered.
The cost of branded pharmaceuticals and quality and availability of generic versions are two key issues facing the U.S. marketplace.
A drug created by Stanford Medicine scientists aimed at a ‘Velcro’-like protein reduces ALS symptoms and improves survival in mice.
Stanford Medicine experts discuss the past successes and future potential of mRNA as a new type of medicine or treatment.
Stanford Medicine researchers weigh in on the promise and peril of increasingly popular diabetes drugs being used for weight loss.
